department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

insulin · pharmadog

pharmadog
drugs
insulin

drug

patient view →

insulin

updated 2mo ago

by Shanghai Jiao Tong University

community read0 votes

all catalysts(2)

phase 0 trial completion · 1

phase 0 trial completion

Shanghai Jiao Tong University — insulin (Phase 0 Trial Completion)

phase 2 completion · 1

phase 2 completion

Diabete Quebec — insulin (Phase II Trial Completion)

News(1)

Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs
“We're basically not using our body as directed,” says "Drug Story" host Thomas Goetz.
stat · 2mo ago

Data sources

ClinicalTrials.gov

last refreshed 25m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagRecall90 co-mentions · 24 sources
tagApproval86 co-mentions · 43 sources
tagType 2 Diabetes47 co-mentions · 12 sources
drugAFREZZA28 co-mentions · 14 sources
drugSOLIQUA 100/3324 co-mentions · 12 sources
company$TNDMTANDEM DIABETES CARE INC21 co-mentions · 7 sources
tagType 1 Diabetes20 co-mentions · 2 sources
druginsulin degludec LA16 co-mentions · 16 sources

Trials studying insulin

phase3A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Beforecompletedn=1,085
—A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugaractive not recruitingn=245
phase3A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetesrecruitingn=877
phase3A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)completedn=485
phase3A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetescompletedn=148
phase2INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetesrecruitingn=100
—The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in Francerecruitingn=350
phase1Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutationsterminatedn=34

more trials →